Progressive Multifocal Leukoencephalopathy: Serial High-b-Value Diffusion-Weighted MR Imaging and Apparent Diffusion Coefficient Measurements to Assess Response to Highly Active Antiretroviral Therapy

References

1. ↵
   Berger JR, Major EO. Progressive multifocal leukoencephalopathy. Semin Neurol 1999;19:193–200

   PubMedWeb of Science
2. ↵
   Tassie JM, Gasnault J, Bentata M, et al. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors: Clinical Epidemiology Group. French Hospital Database on HIV. AIDS 1999;13:1881–87

   CrossRefPubMedWeb of Science
3. ↵
   Ohta K, Obara K, Sakauchi M, et al. Lesion extension detected by diffusion-weighted magnetic resonance imaging in progressive multifocal leukoencephalopathy. J Neurol 2001;248:809–11

   CrossRefPubMed
4. ↵
   Henderson RD, Smith MG, Mowat P, et al. Progressive multifocal leukoencephalopathy. Neurology 2002;58:1825

   FREE Full Text
5. ↵
   Bergui M, Bradac GB, Oguz KK, et al. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology 2004;46:22–25. Epub 2003 Oct 31

   CrossRefPubMed
6. ↵
   Post MJ, Yiannoutsos C, Simpson D, et al. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol 1999;20:1896–906

   Abstract/FREE Full Text
7. ↵
   Thurnher MM, Post MJ, Rieger A, et al. Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol 2001;22:977–84

   Abstract/FREE Full Text